A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Abemaciclib Impurity 45 - Request Quote

Picture of Abemaciclib Impurity 45

Abemaciclib Impurity 45

SZ CAT No:SZ-A077062
CAS No
NA
Mol.F.
C30H27F4N9
Mol.Wt.
589.6
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Abemaciclib Impurity 45 is chemically Bis(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-yl)amine. Abemaciclib Impurity 45 is supplied with detailed characterization data compliant with regulatory guideline. Abemaciclib Impurity 45 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Abemaciclib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Abemaciclib Impurity 45

Purchase Abemaciclib Impurity 45

Abemaciclib Impurity 45 suppliers

Abemaciclib Impurity 45 manufacturers

Abemaciclib Impurity 45 price

Order Abemaciclib Impurity 45

Enquire Abemaciclib Impurity 45

Abemaciclib Impurity 45 cost

Abemaciclib Impurity 45 Supplier

Abemaciclib Impurity 45 Distributor

Abemaciclib Impurity 45 for Method Validation

Abemaciclib Reference Standard

Abemaciclib Impurity 45 for ANDA Filing

Abemaciclib Impurity 45 for Forced Degradation Studies

Abemaciclib Impurity 45 Identification Standards

Abemaciclib Impurity 45 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,